17th Mar 2022

Custom Pharma awarded funding from BEIS

We are very pleased to be able to share the news we have been awarded funding from BEIS through their Medicines and Diagnostics Manufacturing Transformation Fund (MDMTF). This fund was established to support businesses investing in life sciences manufacturing projects in the UK and was the predecessor to the new Life Sciences Innovative Manufacturing Fund (LSIMF).

This funding will help with our plans to build our new facility in Brighton that will create capacity to manufacture and develop difficult to handle, high potency medicines for the UK NHS and export biopharmaceuticals market, as previously announced.  We are very proud to have been selected to benefit from this funding and form part of the growth of the life sciences sector here in the UK.

To read more about our plans for the new facility please read our previous news here.